Meise Medizintechnik GmbH

14/12/2021

08/12/2021

Zwischenanalyse der COSA (COVID-19Patienten behandelt mit dem Seraph® 100 Microbind® Affinity filter)

AbstractBackground. The Seraph®100 Microbind Affinity Blood Filter® is a hemoperfusion device that is licensed for the reduction of pathogens, including several

18/11/2021

Seraph 100 – Aufbau & Anleitung

18/11/2021

Seraph 100 and Blutkreislaufinfektionen
https://www.youtube.com/watch?v=sRKOyHUAX0M
Mehr Informationen zum Produkt:
https://www.meise.com/en/products/dialysis/blood-filter.html

Seraph 100 reduces pathogens circulating in the blood by mimicking the biological activity of naturally-occurring receptor sites on the endothelium to bind b...

18/11/2021

Mehr als die Reduzierung von Krankheitserregern -
Seraph 100 In COVID-19
Prof. Kielstein, Dr. Julius Schmidt, Dr. Brian Rifkin

Clinicians in Europe and the United States report on their experience in treating COVID-19 with Seraph 100.Presenters:00:00 Introduction01:15 Professor Jan K...

18/11/2021

COVID-19 Webinar: Aufgaben von Seraph 100
Prof. Lui Lorni, Dr. Stefan Büttner; Prof. Kielstein

18/11/2021

Seraph 100 User Group II

Hear clinicians discuss their experience with the Seraph 100 hemoperfusion adsorption column to treat COVID-19 patients.0:00 Introduction1:45 Product Overvie...

18/11/2021

Seraph 100 User Group III
Case Reports

Hear clinicians discuss their experience with the Seraph 100 hemoperfusion adsorption column to treat COVID-19 patients.0:00 Case Discussion2:43 Introduction...

18/11/2021

Die frühe Phase der Sepsis -
Aktuelle Strategien & Optionen für die Zukunft

Prof. Herwig Gerlach, Prof. Lakhmir Chawla

e-ISICEM ExThera Medical Satellite September 15th, 2020Speakers:Professor Herwig Gerlach, MD PhD MBA MSc MAEProfessor and Chairman of Department for Anesthes...

18/11/2021

Sepsis & COVID 19: Eine Aufgabe für Seraph 100
Prof. Lakhmir Chawla, USA

Professor Mink Chawla presents on the treatment of sepsis and COVID-19 using Seraph 100.L40057